The content is available as a PDF (338.7 KB).
letter . 2020 Apr 11:ciaa426. doi: 10.1093/cid/ciaa426
Good IgA bad IgG in SARS-CoV-2 infection?
Marie C Béné
1,✉, Marcelo de Carvalho
2, Marion Eveillard
1, Yannick Lebri
1
Marie C Béné
1
Hematology Biology, Nantes University Hospital & CRCINA, Nantes, France
Find articles by Marie C Béné
Marcelo de Carvalho
2
Bittencourt Immunology Laboratory, Nancy University Hospital & IMOPA UMR7365, Nancy, France
Find articles by Marcelo de Carvalho
Marion Eveillard
1
Hematology Biology, Nantes University Hospital & CRCINA, Nantes, France
Find articles by Marion Eveillard
Yannick Lebri
1
Hematology Biology, Nantes University Hospital & CRCINA, Nantes, France
Find articles by Yannick Lebri
1
Hematology Biology, Nantes University Hospital & CRCINA, Nantes, France
2
Bittencourt Immunology Laboratory, Nancy University Hospital & IMOPA UMR7365, Nancy, France
✉
Address correspondence to: Pr Marie C Béné, Service d’Hématologie Biologique, Pôle Laboratoires PHU7, 9 quai Moncousu, 44000 Nantes, France, mariecbene@gmail.com
Received 2020 Apr 5.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7184351 PMID: 32280952